Episode 361: 260. METHODS MONDAY-- EVENT RATE

from Questioning Medicine · host Questioning Medicine

Methods Monday --- Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review | Cardiology | JAMA Network Open | JAMA Network During the design of a randomized clinical trial (RCT), estimation of the expected event rate and effect size is a key component to calculating the sample size. Overly optimistic estimation of event rates and effect sizes may lead to underpowered trials. If you expect 1 event per 100 people and you are looking for 5 events then you only need to enroll….. 500 people but if the actual event rate is 1 per 200 people then in order to get 5 events you need to enroll 1000 people!! You can see enrolling 500 people instead of 1000 would underpower your trial This article, published in JAMA Network Open in April 2024, presents a systematic review of 344 contemporary cardiovascular randomized clinical trials (RCTs) to evaluate the accuracy of estimated event rates and effect sizes1. The key findings are:Event rates were frequently overestimated: Median observed event rate: 9.0% (IQR, 4.3%-21.4%) Median estimated event rate: 11.0% (IQR, 6.0%-25.0%) 61.1% of trials overestimated the event rate 1Effect sizes were often overestimated: Median observed effect size: 0.91 (IQR, 0.74-0.99) Median estimated effect size: 0.72 (IQR, 0.60-0.80) 82.1% of trials overestimated the effect size The drug companies think their drug is way better than it is or observed to be in trials1Device trials were independently associated with decreased accuracy of event rate estimation compared to drug trials1.The study concludes that the frequent overestimation of event rates and effect sizes in cardiovascular RCTs may contribute to underpowered trials and the inability to adequately test trial hypotheses1. This finding has implications for trial design—if we are not accurate or realistic about the interventions we are likely to underpower the study which means you have to do the whole thing all over again or likely all over again and risk FDA rejecting you drug.

Episode metadata supplied by the publisher feed · Published Jan 13, 2025

What this episode covers

Methods Monday --- Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review | Cardiology | JAMA Network Open | JAMA Network During the design of a randomized clinical trial (RCT), estimation of the expected event rate and effect size is a key component to calculating the sample size. Overly optimistic estimation of event rates and effect sizes may lead to underpowered trials. If you expect 1 event per 100 people and you are looking for 5 events then you only need to enroll….. 500 people but if the actual event rate is 1 per 200 people then in order to get 5 events you need to enroll 1000 people!! You can see enrolling 500 people instead of 1000 would underpower your trial This article, published in JAMA Network Open in April 2024, presents a systematic review of 344 contemporary cardiovascular randomized clinical trials (RCTs) to evaluate the accuracy of estimated event rates and effect sizes1. The key findings are:Event rates were frequently overestimated:Median observed event rate: 9.0% (IQR, 4.3%-21.4%)Median estimated event rate: 11.0% (IQR, 6.0%-25.0%)61.1% of trials overestimated the event rate1Effect sizes were often overestimated:Median observed effect size: 0.91 (IQR, 0.74-0.99)Median estimated effect size: 0.72 (IQR, 0.60-0.80)82.1% of trials overestimated the effect sizeThe drug companies think their drug is way better than it is or observed to be in trials1Device trials were independently associated with decreased accuracy of event rate estimation compared to drug trials1.The study concludes that the frequent overestimation of event rates and effect sizes in cardiovascular RCTs may contribute to underpowered trials and the inability to adequately test trial hypotheses1. This finding has implications for trial design—if we are not accurate or realistic about the interventions we are likely to underpower the study which means you have to do the whole thing all over again or likely all over again and risk FDA rejecting you drug.

PodParley-generated summary based on available episode metadata and transcript content.

NOW PLAYING

Episode 361: 260. METHODS MONDAY-- EVENT RATE

0:00 10:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

The Law Of Detachment & Redefining Success

Mar 5, 2026 ·8m

S2. Ep.3: 3 True Night Terrors

Feb 23, 2026 ·22m

S2 Ep.2: Antique Clocks, Burnt Face Man &Ghostly Calls

Feb 16, 2026 ·19m

S2 Ep1: Whistles, mirrors & Ghost At The MALL

Feb 9, 2026 ·28m

Ep.80: Skeptic VS Believer

Feb 8, 2026 ·39m

Ep.79: Dogman vs Hell Hound

Feb 8, 2026 ·37m

Similar Podcasts

The Health Odyssey: Navigating Tomorrow's Medicine Podcast Welcome to 'The Health Odyssey: Navigating Tomorrow's Medicine,' where we embark on an adventurous journey through the ever-evolving world of healthcare. Each episode is like a treasure map, guiding you through the rich tapestry of ancient healing arts mixed with futuristic tech wizardry. We’ll chat about the wild west of health data privacy, the corporate giants reshaping our care, and the mind-bending potential of psychedelics for mental wellness. Think of us as your trusty sidekicks, unraveling the mysteries of modern medicine while keeping it real and relatable. Let’s dive into the stories, the science, and the soul of healthcare, paving the way for a healthier tomorrow. Lynne's Podcast Lynne August MD Dr. A offers her interpretations and applications of Dr. Revici’s profound research at DrRevici.com and the Revici Journal. Dr. Revici was arguably fifty to one hundred years ahead of his time in his application of quantum physics to medical sciences. As a once-aspiring physicist, this alone propelled Dr. A to Dr. Revici. As a physician, she felt compelled, and in some palpable way responsible, to understand Dr. Revici’s ability to control pain and achieve remissions in terminal cancer patients with his non-toxic “guided chemotherapy”, even many cancers that conventional therapy failed to control. Most of the time his questions and solutions were as unprecedented as they were effective. While Dr. Revici was primarily focused on cancer, Dr. A’s research and therapeutics to prevent and treat all chronic and degenerative disease can transform 21st century medicine. Dance Med Spotlight Alyssa Arms We dive into the world of dance medicine and science. Our goal is to provide valuable insights & practical knowledge to established professionals, individuals interested in working with dancers, and the dance community as a whole. Tune in to Dance Med Spotlight for amazing conversations with experts, dance industry professionals, & dance community members. Host: Alyssa Arms Rania Awaad Muslim Central Dr. Rania Awaad M.D., is a Clinical Associate Professor of Psychiatry at the Stanford University School of Medicine where she is the Director of the Stanford Muslim Mental Health & Islamic Psychology Lab as well as Stanford University’s Affiliate Chaplain. In the community, she serves as the Executive Director of Maristan.org, a holistic mental health nonprofit serving Muslim communities, and the Director of The Rahmah Foundation, a non-profit organization dedicated to educating Muslim women and girls. In addition, she is faculty of Islamic Psychology at Cambridge Muslim College and The Islamic Seminary of America.She is also a Senior Fellow for Yaqeen Institute and the Institute of Social Policy and Understanding. Prior to studying medicine, she pursued classical Islamic studies in Damascus, Syria, and holds certifications (ijaza) in the Qur’an, Islamic Law, and other branches of the Islamic Sciences.

Frequently Asked Questions

How long is this episode of Questioning Medicine?

This episode is 10 minutes long.

When was this Questioning Medicine episode published?

This episode was published on January 13, 2025.

What is this episode about?

Can I download this Questioning Medicine episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!